| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 3B974D670O |
| InChI Key | IPEXHQGMTHOKQV-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C14H17ClN2O2 |
| Molecular Weight | 280.76 |
| AlogP | 1.66 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 54.12 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 18.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Rho-associated protein kinase inhibitor | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Kinase
Protein Kinase
AGC protein kinase group
AGC protein kinase DMPK family
AGC protein kinase ROCK subfamily
|
- | 186 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Erectile Dysfunction | 2 | D007172 | ClinicalTrials |
| Coronary Disease | 2 | D003327 | ClinicalTrials |
| Renal Insufficiency, Chronic | 1 | D051436 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3545341 |
| EPA CompTox | DTXSID80655294 |
| FDA SRS | 3B974D670O |
| PubChem | 15604510 |
| SureChEMBL | SCHEMBL952603 |
| ChEMBL | CHEMBL1667969 |
| FDA SRS | 3B974D670O |
| Guide to Pharmacology | 8910 |
| PubChem | 15604510 |
| SureChEMBL | SCHEMBL952213 |
| ZINC | ZINC000034603838 |